Skip to main navigation Skip to search Skip to main content

Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus-2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019

  • Thomas R. O'Brien
  • , David L. Thomas
  • , Sarah S. Jackson
  • , Ludmila Prokunina-Olsson
  • , Raymond P. Donnelly
  • , Rune Hartmann
    • National Institutes of Health (NIH)
    • Johns Hopkins University
    • United States Food and Drug Administration

    Research output: Contribution to journal/newspaper › Editorial › peer-review

    74 Citations (Scopus)
    Original languageEnglish
    JournalClinical Infectious Diseases
    Volume71
    Issue6
    Pages (from-to)1410-1412
    Number of pages3
    ISSN1058-4838
    DOIs
    Publication statusPublished - 15 Sept 2020

    Keywords

    • Innate immunity
    • MERS-CoV
    • SARS-CoV
    • Severe acute respiratory syndrome
    • Virology

    Cite this